BIO Comment on EU Compulsory Licensing Legislation

July 31, 2023

Download Full Comments Below

BIO Comment on EU CL Patent Legislation - Exec Summary - FINAL__

Download

Discover More

BIO Comments to FDA on Using Artificial…

In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.

Learn more

BIO Comments on the NIH Technology Transfer…

BIO provides detailed comments in advance of the July 31, 2023 NIH Workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.

Learn more

BIO Statement to the Senate 340B Bipartisan…

In response to a Request for Information (RFI) from the Senate 340B Bipartisan Working Group, BIO submitted detailed comments on the current status of the program and suggestions for improvements.

Learn more